Medicare Enrolled

Dr. Neil Gershman, M.D.

Allergy & Immunology · Miami, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
7800 SW 87TH AVE, Miami, FL 33173
3055950109
Registered in NPPES since 2005
NPI: 1851389985 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gershman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gershman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gershman

Dr. Neil Gershman is an allergy & immunology specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gershman performed 23,084 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Gershman received a total of $19,033 from 37 pharmaceutical and/or device companies across 677 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gershman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 11% volume in FL $19,033 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
23,084
Medicare services
Top 11% in FL for allergy & immunology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tezepelumab injection, 1 mg
An injection of tezepelumab-ekko, a medication administered in 1 mg doses.
8,197 $14 $48
Omalizumab injection (Xolair) for asthma/allergy 5,012 $30 $111
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
4,950 $3 $10
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
1,550 $11 $35
Skin allergy test
A test where small amounts of potential allergens are injected into the skin to check for allergic reactions.
1,268 $6 $12
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
966 $9 $35
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
356 $67 $149
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
265 $11 $54
Health risk assessment administration and interpretation
This procedure involves administering a health risk assessment to a patient and interpreting the results.
148 $2 $16
Allergen injection administration
Professional service for the administration of a single allergen injection.
105 $7 $30
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
92 $118 $324
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
58 $29 $250
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
56 $21 $149
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
47 $93 $175
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
14 $14 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,033
Total received (2018-2024)
Avg $2,719/year across 7 years
Top 18% in FL for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
677
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,935
2023
$3,345
2022
$2,363
2021
$2,160
2020
$1,542
2019
$2,723
2018
$3,965

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$474
GENZYME CORPORATION
$447
Regeneron Healthcare Solutions, Inc.
$310
GlaxoSmithKline, LLC.
$281
Optinose US, Inc.
$213
BioCryst US Sales Co., LLC
$183
Blueprint Medicines Corporation
$153
Amgen Inc.
$146
Takeda Pharmaceuticals U.S.A., Inc.
$140
X4 Pharmaceuticals, Inc.
$135
LEO Pharma Inc.
$98
Grifols Shared Services North America, Inc.
$94
CSL Behring
$58
Pharming Healthcare, Inc.
$48
PFIZER INC.
$46
ABBVIE INC.
$46
Novartis Pharmaceuticals Corporation
$30
ADMA BioManufacturing LLC
$16
kaleo, Inc.
$16
Top 3 companies account for 42.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,234
GlaxoSmithKline, LLC.
$3,125
ALK-Abello, Inc
$2,120
GENZYME CORPORATION
$2,090
Regeneron Healthcare Solutions, Inc.
$915
Takeda Pharmaceuticals U.S.A., Inc.
$670
CSL Behring
$659
Boehringer Ingelheim Pharmaceuticals, Inc.
$647
PFIZER INC.
$532
Pharming Healthcare, Inc.
$419
Optinose US, Inc.
$392
Octapharma USA, Inc.
$356
OptiNose US, Inc.
$337
LEO Pharma Inc.
$324
BioCryst US Sales Co., LLC
$297
Amgen Inc.
$297
Novartis Pharmaceuticals Corporation
$277
Shire North American Group Inc
$276
Blueprint Medicines Corporation
$272
Genentech USA, Inc.
$229
kaleo, Inc.
$214
ABBVIE INC.
$164
Incyte Corporation
$139
X4 Pharmaceuticals, Inc.
$135
Sunovion Pharmaceuticals Inc.
$129
Teva Pharmaceuticals USA, Inc.
$125
Kaleo, Inc.
$121
Grifols USA, LLC
$116
SANOFI-AVENTIS U.S. LLC
$99
Grifols Shared Services North America, Inc.
$94
Mylan Specialty L.P.
$78
AIMMUNE THERAPEUTICS, INC.
$52
Bio Products Laboratory USA, Inc.
$27
Aimmune Therapeutics, Inc.
$19
NOVARTIS PHARMACEUTICALS CORPORATION
$19
ADMA BioManufacturing LLC
$16
Hikma Pharmaceuticals USA
$16
Top 3 companies account for 44.5% of all-time payments
Associated products mentioned in payments ›
ADBRY · AIRSUPRA · ANORO · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · ArmonAir Digihaler · Auvi-Q · BREO · BREZTRI · BREZTRI AEROSPHERE · CIBINQO · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DERMATITIS - DISEASE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EUCRISA · FARXIGA · FASENRA · GLASSIA · Gammaplex · Gamunex-C · Grastek · HYQVIA · Haegarda · Hizentra · Kcentra · LATUDA · LONHALA MAGNAIR · NUCALA · OPZELURA · ORLADEYO · Odactra · PALFORZIA · PANZYGA · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · RINVOQ · RUCONEST · Ragwitek · Ryaltris · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · Utibron · XOLAIR · XOLREMDI · Xembify · Xhance · Xolair · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an allergy & immunology specialist in Miami?
Compare allergy & immunologists in the Miami area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists in nearby ZIP areas
46
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
BAPTIST HOSPITAL OF MIAMI
3.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gershman is a mixed practice specialist, with above-average Medicare volume (top 11% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gershman experienced with tezepelumab injection, 1 mg?
Based on Medicare claims data, Dr. Gershman performed 8,197 tezepelumab injection, 1 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gershman receive payments from pharmaceutical companies?
Yes. Dr. Gershman received a total of $19,033 from 37 companies across 677 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gershman's costs compare to other allergy & immunologists in Miami?
Dr. Gershman's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gershman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →